Be Curious About Your Health

Continue to Be Curious About Your Health

In Alzheimer’s disease, changes in the brain begin 10 to 20 years before symptoms of memory loss or changes in thinking appear.

Welcome to the TRAILBLAZER-ALZ 3 Study, where we’re exploring a potential treatment to delay or prevent the onset of Alzheimer’s.

We’re looking for men and women ages 65-80 who have normal memory, thinking, mood, and behavior patterns, but who may be at risk for developing Alzheimer’s disease in the future.

We’re evaluating an investigational drug to see if it might potentially halt or slow the onset of Alzheimer’s disease symptoms of memory loss by treating the early changes in the brain.

All study-related care will be provided at no cost to you.  Health insurance is not required and your time and travel will be compensated.

Participants are randomly assigned to one of two groups. They receive either the investigational drug or a placebo (a substance that looks like the investigational drug but contains no active ingredients). Those who enter the study and receive the placebo may have the option to receive the investigational drug at a later time.

If you qualify, participation can last as long as approximately 5 years but will vary for each participant.

A Welcome Message from Dr. Eric Grigsby

Listen to this brief message from Dr. Grigsby, Principal Investigator,  detailing his qualifications and background.

Ready to Learn more?

Call us at 707-252-9606 or email at

Dr. reviewing brain scans while studying Alzheimer's

This screening event is meant for those who:

  • Are 65 to 80 years of age
  • Have normal memory, thinking, mood, and behavior patterns

This event is part of an Alzheimer’s prevention clinical research study, TRAILBLAZER-ALZ 3, which is exploring options to stop or slow down the appearance of memory and thinking problems associated with Alzheimer’s disease.

Ready to Learn more?

Call us at 707-252-9606 or email at

Dr Grigsby - CEO and Founder of Neurovations
Dr Grigsby | CEO and Founder of Neurovations


Neurovations, a patient care and innovation company, was founded in 1992 by CEO Dr. Eric Grigsby. Today, Neurovations is a national leader in medical device and pharmaceutical innovation, clinical research, and a world-class education program focusing in pain and neuroscience. Dr. Grigsby is deeply connected to the healthcare community through our non-profit HealthRoots Foundation and to the Napa community through Rocca Family Vineyards, a producer of award-winning wines.

Our unwavering mission is to inspire hope and to contribute to the health and well-being of our patients and communities through integrated clinical practice, research, and education.